Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma

NCT01393340 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Nasal Polyposis
Asthma

Interventions

DRUG: Omalizumab
DRUG: Placebo

Sponsor

University Hospital, Ghent

Collaborators

[object Object]